Immediate cephalosporin allergy.
Adult
Aged
Anti-Bacterial Agents
/ adverse effects
Cephalosporins
/ adverse effects
Cross Reactions
/ immunology
Drug Hypersensitivity
/ diagnosis
Erythema
/ chemically induced
Female
Humans
Hypersensitivity, Immediate
/ diagnosis
Immunoglobulin E
/ immunology
Male
Middle Aged
Penicillins
/ adverse effects
Retrospective Studies
Skin Tests
IgE-mediated
beta-lactam
cephalosporin allergy
cross-reactivity
side chain
Journal
Internal medicine journal
ISSN: 1445-5994
Titre abrégé: Intern Med J
Pays: Australia
ID NLM: 101092952
Informations de publication
Date de publication:
08 2019
08 2019
Historique:
received:
13
08
2018
revised:
18
12
2018
accepted:
09
01
2019
pubmed:
23
1
2019
medline:
10
4
2020
entrez:
23
1
2019
Statut:
ppublish
Résumé
Patients who suffer from acute IgE-mediated allergy to a cephalosporin antibiotic are frequently assumed to be at high risk of allergy to other cephalosporins and penicillins. To define cross-reactivity patterns in patients with confirmed allergy to a cephalosporin. Subjects presenting with a history of immediate allergy to a cephalosporin-family antibiotic between March 2009 and July 2017 were investigated with specific IgE testing to penicillin, amoxycillin and cefaclor, followed by skin prick testing, intradermal testing and drug provocation testing with a panel of penicillins and cephalosporins. Out of 564 subjects with a reported beta-lactam allergy, 90 identified a cephalosporin as their index drug. Fifty-five (61.1%) of the 90 subjects tested had a history consistent with an IgE-mediated reaction, of whom 24 (43.6%) were proven to be allergic to their index cephalosporin. Twenty (83.3%) of the 24 were allergic only to their index cephalosporin. Of the four remaining subjects, two were co-sensitised to another beta-lactam with a similar side chain, while the other two had no specific cross-reactivity pattern. Major and minor penicillin determinants were negative for all cephalosporin-allergic individuals. In our cohort, cephalosporin allergy does not appear to be a class effect, with most cases found allergic only to their index cephalosporin. Co-sensitisation to other cephalosporins or penicillins was uncommon, and when it occurred, was usually consistent with side chain cross-reactivity.
Sections du résumé
BACKGROUND
Patients who suffer from acute IgE-mediated allergy to a cephalosporin antibiotic are frequently assumed to be at high risk of allergy to other cephalosporins and penicillins.
AIM
To define cross-reactivity patterns in patients with confirmed allergy to a cephalosporin.
METHODS
Subjects presenting with a history of immediate allergy to a cephalosporin-family antibiotic between March 2009 and July 2017 were investigated with specific IgE testing to penicillin, amoxycillin and cefaclor, followed by skin prick testing, intradermal testing and drug provocation testing with a panel of penicillins and cephalosporins.
RESULTS
Out of 564 subjects with a reported beta-lactam allergy, 90 identified a cephalosporin as their index drug. Fifty-five (61.1%) of the 90 subjects tested had a history consistent with an IgE-mediated reaction, of whom 24 (43.6%) were proven to be allergic to their index cephalosporin. Twenty (83.3%) of the 24 were allergic only to their index cephalosporin. Of the four remaining subjects, two were co-sensitised to another beta-lactam with a similar side chain, while the other two had no specific cross-reactivity pattern. Major and minor penicillin determinants were negative for all cephalosporin-allergic individuals.
CONCLUSION
In our cohort, cephalosporin allergy does not appear to be a class effect, with most cases found allergic only to their index cephalosporin. Co-sensitisation to other cephalosporins or penicillins was uncommon, and when it occurred, was usually consistent with side chain cross-reactivity.
Substances chimiques
Anti-Bacterial Agents
0
Cephalosporins
0
Penicillins
0
Immunoglobulin E
37341-29-0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
985-993Informations de copyright
© 2019 Royal Australasian College of Physicians.